Network News

First pivotal Phase III study exPDite-2 for allogeneic pluripotent stem cell therapy Bemdaneprocel initiated / Phase II gene therapy study REGENERATE-PD with AB-1005 initiated in the United Kingdom and Poland, Germany to follow soon and continuing in the US / Parkinson’s disease is the second most common and fastest growing neurodegenerative disease, affecting more than […]

State of Baden-Württemberg funds the intensifying of existing cooperative relations with ten million euros On the basis of the cooperative relations that have developed over time, Heidelberg University and Harvard University are going to deepen and expand their cooperation. Prof. Dr Alan M. Garber, President of Harvard University, and Prof. Dr Frauke Melchior, Rector of […]

The shortlist of the Cancer Grand Challenges selection process 2025 has been announced and Roman Sarott, Research Group Leader at the Max Planck Institute for Medical Research, Heidelberg and Heilbronn, has been selected for the final stages as part of team NeoCircuit. The team tackles the challenge of developing and applying novel ways to rewire cancer […]

About five percent of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all patients with these fusions the same way. However, new research led by scientists from the […]

Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg University to develop a therapeutic vaccination concept that can mobilize the immune system to target cancer cells. The team showed that virus peptides coupled to silica nanoparticles can elicit effective T-cell responses against HPV-related tumors. In a mouse […]

European Research Council funds groundbreaking projects by early-career researchers The European Research Council is awarding four valuable grants to Heidelberg University. These ERC Starting Grants go to researchers in early stages of their career who want to carry out groundbreaking research with ERC funding. They include Dr Michael Gerlt, who will do research at the […]

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model. Heidelberg, Germany, August 19th, 2025. BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new collaboration with Novo Nordisk, […]

FOXP1 syndrome is a congenital disorder in which the brain development of affected children is severely impaired due to a genetic variant. To date, there are no treatments that target the root cause of the disorder. A research team from the Medical Faculty Heidelberg at Heidelberg University has now demonstrated in mice, that the inhibition […]

A great honor for Professor Dr. Dr. Stefan Listl from the Medical Faculty of Heidelberg University: The International Association for Dental, Oral, and Craniofacial Research (IADR) honored him at its annual meeting with the prestigious Distinguished Scientist Award in the field of social science, epidemiology, and health services research. This award is one of the […]